Skip to main content
Top
Published in: Inflammation 2/2014

01-04-2014

IL-6 Trans-Signaling Enhances CCL20 Production from IL-1β-Stimulated Human Periodontal Ligament Cells

Authors: Yoshitaka Hosokawa, Satoru Shindo, Ikuko Hosokawa, Kazumi Ozaki, Takashi Matsuo

Published in: Inflammation | Issue 2/2014

Login to get access

Abstract

CC chemokine ligand 20 (CCL20) plays a central role in the recruitment of CCR6-expressing cells, including Th17 cells which are related to bone resorption in periodontal lesions and thus in the development of periodontal disease. IL-6 is an important cytokine that is associated with the pathogenesis of periodontitis. However, the effect of IL-6 on CCL20 production is uncertain. The aim of this study was to examine whether IL-6 could modify CCL20 expression in human periodontal ligament cells (HPDLCs). HPDLCs expressed gp130 but did not express IL-6R on the surface of HPDLCs. So, IL-6 trans-signaling is important to recognize IL-6 by HPDLCs. IL-6/sIL-6R stimulation enhanced CCL20 production in IL-1β-stimulated HPDLCs. IL-6 produced from IL-1β-stimulated HPDLCs with sIL-6R could increase CCL20 production in HPDLCs with sIL-6R. Signal transducer and activator of transcription (STAT)3 activation was related to CCL20 production in IL-1β and IL-6/sIL-6R-stimulated HPDLCs. Our data suggests that HPDLCs, in response to IL-6, sIL-6R, and IL-1β, may shift chemokine production to that favoring CCR6-expressing cells recruitment in periodontal lesions.
Literature
1.
go back to reference Garlet, G.P. 2010. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defence and tissue destruction viewpoints. Journal of Dental Research 89: 1349–1363.PubMedCrossRef Garlet, G.P. 2010. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defence and tissue destruction viewpoints. Journal of Dental Research 89: 1349–1363.PubMedCrossRef
2.
go back to reference Di Benedetto, A., I. Gigante, S. Colucci, and M. Grano. 2013. Periodontal disease: linking the primary inflammation to bone loss. Clinical and Developmental Immunology 2013: 503754.PubMedCentralPubMedCrossRef Di Benedetto, A., I. Gigante, S. Colucci, and M. Grano. 2013. Periodontal disease: linking the primary inflammation to bone loss. Clinical and Developmental Immunology 2013: 503754.PubMedCentralPubMedCrossRef
3.
go back to reference Liu, Y.C., U.H. Lerner, and Y.T. Teng. 2010. Cytokine responses against periodontal infection: protective and destructive roles. Periodontology 2000 52: 163–206.PubMedCrossRef Liu, Y.C., U.H. Lerner, and Y.T. Teng. 2010. Cytokine responses against periodontal infection: protective and destructive roles. Periodontology 2000 52: 163–206.PubMedCrossRef
4.
go back to reference Afzali, B., G. Lombardi, R.I. Lechler, and G.M. Lord. 2007. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clinical and Experimental Immunology 148: 32–46.PubMedCentralPubMedCrossRef Afzali, B., G. Lombardi, R.I. Lechler, and G.M. Lord. 2007. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clinical and Experimental Immunology 148: 32–46.PubMedCentralPubMedCrossRef
5.
go back to reference Hirota, K., H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, N. Sakaguchi, and S. Sakaguchi. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. Journal of Experimental Medicine 204: 2803–2812.PubMedCentralPubMedCrossRef Hirota, K., H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, N. Sakaguchi, and S. Sakaguchi. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. Journal of Experimental Medicine 204: 2803–2812.PubMedCentralPubMedCrossRef
6.
go back to reference Hosokawa, Y., T. Nakanishi, D. Yamaguchi, K. Takahashi, H. Yumoto, K. Ozaki, and T. Matsuo. 2002. Macrophage inflammatory protein 3alpha-CC chemokine receptor 6 interactions play an important role in CD4+ T-cell accumulation in periodontal diseased tissue. Clinical and Experimental Immunology 128: 548–554.PubMedCentralPubMedCrossRef Hosokawa, Y., T. Nakanishi, D. Yamaguchi, K. Takahashi, H. Yumoto, K. Ozaki, and T. Matsuo. 2002. Macrophage inflammatory protein 3alpha-CC chemokine receptor 6 interactions play an important role in CD4+ T-cell accumulation in periodontal diseased tissue. Clinical and Experimental Immunology 128: 548–554.PubMedCentralPubMedCrossRef
7.
go back to reference Bendtzen, K. 1988. Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunology Letters 19: 183–191.PubMedCrossRef Bendtzen, K. 1988. Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunology Letters 19: 183–191.PubMedCrossRef
8.
go back to reference Palmqvist, P., P. Lundberg, I. Lundgren, L. Hänström, and U.H. Lerner. 2008. IL-1beta and TNF-alpha regulate IL-6-type cytokines in gingival fibroblasts. Journal of Dental Research 87: 558–563.PubMedCrossRef Palmqvist, P., P. Lundberg, I. Lundgren, L. Hänström, and U.H. Lerner. 2008. IL-1beta and TNF-alpha regulate IL-6-type cytokines in gingival fibroblasts. Journal of Dental Research 87: 558–563.PubMedCrossRef
9.
go back to reference Eskan, M.A., M.R. Benakanakere, B.G. Rose, P. Zhang, J. Zhao, P. Stathopoulou, D. Fujioka, and D.F. Kinane. 2008. Interleukin-1 beta modulates proinflammatory cytokine production in human epithelial cells. Infection and Immunity 76: 2080–2089.PubMedCentralPubMedCrossRef Eskan, M.A., M.R. Benakanakere, B.G. Rose, P. Zhang, J. Zhao, P. Stathopoulou, D. Fujioka, and D.F. Kinane. 2008. Interleukin-1 beta modulates proinflammatory cytokine production in human epithelial cells. Infection and Immunity 76: 2080–2089.PubMedCentralPubMedCrossRef
10.
go back to reference Kondo, A., T. Otsuka, R. Matsushima-Nishiwaki, G. Kuroyanagi, J. Mizutani, I. Wada, O. Kozawa, and H. Tokuda. 2013. Inhibition of SAPK/JNK leads to enhanced IL-1-induced IL-6 sythesis in osteoblasts. Archives of Biochemistry and Biophysics 535: 227–233.PubMedCrossRef Kondo, A., T. Otsuka, R. Matsushima-Nishiwaki, G. Kuroyanagi, J. Mizutani, I. Wada, O. Kozawa, and H. Tokuda. 2013. Inhibition of SAPK/JNK leads to enhanced IL-1-induced IL-6 sythesis in osteoblasts. Archives of Biochemistry and Biophysics 535: 227–233.PubMedCrossRef
11.
go back to reference Hashizume, M., N. Hayakawa, and M. Mihara. 2008. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology 47: 1635–1640.PubMedCrossRef Hashizume, M., N. Hayakawa, and M. Mihara. 2008. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology 47: 1635–1640.PubMedCrossRef
12.
go back to reference Bettelli, E., Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235–238.PubMedCrossRef Bettelli, E., Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235–238.PubMedCrossRef
13.
go back to reference Choe, J.Y., K.Y. Park, S.H. Park, S.I. Lee, and S.K. Kim. 2013. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes. Arthritis Research and Therapy 15: R26.PubMedCentralPubMedCrossRef Choe, J.Y., K.Y. Park, S.H. Park, S.I. Lee, and S.K. Kim. 2013. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes. Arthritis Research and Therapy 15: R26.PubMedCentralPubMedCrossRef
14.
go back to reference Bettelli, E., Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235–8.PubMedCrossRef Bettelli, E., Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235–8.PubMedCrossRef
15.
go back to reference Naruishi, K., S. Takashiba, H.H. Chou, H. Arai, F. Nishimura, and Y. Murayama. 1999. Role of soluble interleukin-6 receptor in inflamed gingiva for binding of interleukin-6 to gingival fibroblasts. Journal of Periodontal Research 34: 296–300.PubMedCrossRef Naruishi, K., S. Takashiba, H.H. Chou, H. Arai, F. Nishimura, and Y. Murayama. 1999. Role of soluble interleukin-6 receptor in inflamed gingiva for binding of interleukin-6 to gingival fibroblasts. Journal of Periodontal Research 34: 296–300.PubMedCrossRef
16.
go back to reference Lee, H., A. Herrmann, J.H. Deng, M. Kujawski, G. Niu, Z. Li, S. Forman, R. Jove, D.M. Pardoll, and H. Yu. 2009. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 15: 283–93.PubMedCentralPubMedCrossRef Lee, H., A. Herrmann, J.H. Deng, M. Kujawski, G. Niu, Z. Li, S. Forman, R. Jove, D.M. Pardoll, and H. Yu. 2009. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 15: 283–93.PubMedCentralPubMedCrossRef
17.
go back to reference Lf, C., W. Fischle, E. Verdin, and W.C. Greene. 2001. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293: 1653–7.CrossRef Lf, C., W. Fischle, E. Verdin, and W.C. Greene. 2001. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293: 1653–7.CrossRef
18.
go back to reference Hosokawa, Y., I. Hosokawa, S. Shindo, K. Ozaki, H. Nakae, and T. Matsuo. 2012. Intereukin (IL)-17A synergistically enhances CC chemokine ligand 20 production in IL-1β-stimulated human gingival fibroblasts. Human Immunology 73: 26–30.PubMedCrossRef Hosokawa, Y., I. Hosokawa, S. Shindo, K. Ozaki, H. Nakae, and T. Matsuo. 2012. Intereukin (IL)-17A synergistically enhances CC chemokine ligand 20 production in IL-1β-stimulated human gingival fibroblasts. Human Immunology 73: 26–30.PubMedCrossRef
19.
go back to reference Hosokawa, Y., I. Hosokawa, S. Shindo, K. Ozaki, H. Nakae, and T. Matsuo. 2012. Tumor necrosis factor-like weak inducer of apoptosis increases CC chemokine ligand 20 production in interleukin 1β-stimulated human gingival fibroblasts. Human Immunology 73: 470–473.PubMedCrossRef Hosokawa, Y., I. Hosokawa, S. Shindo, K. Ozaki, H. Nakae, and T. Matsuo. 2012. Tumor necrosis factor-like weak inducer of apoptosis increases CC chemokine ligand 20 production in interleukin 1β-stimulated human gingival fibroblasts. Human Immunology 73: 470–473.PubMedCrossRef
20.
go back to reference Tschopp, J., F. Martinon, and K. Burns. 2003. NALPs: a novel protein family involved in inflammation. Nature Reviews Molecular Cell Biology 4: 95–104.PubMedCrossRef Tschopp, J., F. Martinon, and K. Burns. 2003. NALPs: a novel protein family involved in inflammation. Nature Reviews Molecular Cell Biology 4: 95–104.PubMedCrossRef
21.
go back to reference Le Goff, B., F. Blanchard, J.M. Berthelot, D. Heymann, and Y. Maugars. 2010. Role of interleukin-6 in structural joint damage and systematic bone loss in rheumatoid arthritis. Joint, Bone, Spine 77: 201–205.PubMedCrossRef Le Goff, B., F. Blanchard, J.M. Berthelot, D. Heymann, and Y. Maugars. 2010. Role of interleukin-6 in structural joint damage and systematic bone loss in rheumatoid arthritis. Joint, Bone, Spine 77: 201–205.PubMedCrossRef
22.
go back to reference Nishimoto, N., and T. Kishimoto. 2006. Interleukin 6: from bench to bedside. Nature Clinical Practice Rheumatology 2: 619–626.PubMedCrossRef Nishimoto, N., and T. Kishimoto. 2006. Interleukin 6: from bench to bedside. Nature Clinical Practice Rheumatology 2: 619–626.PubMedCrossRef
Metadata
Title
IL-6 Trans-Signaling Enhances CCL20 Production from IL-1β-Stimulated Human Periodontal Ligament Cells
Authors
Yoshitaka Hosokawa
Satoru Shindo
Ikuko Hosokawa
Kazumi Ozaki
Takashi Matsuo
Publication date
01-04-2014
Publisher
Springer US
Published in
Inflammation / Issue 2/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9750-8

Other articles of this Issue 2/2014

Inflammation 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine